Surgery, Gastroenterology and Oncology
Vol. 22, No. 2, June 2017
All About Percutaneous Biliary Drainage in Unresectable Cholangiocarcinoma
Mihai Ranete, Mugur Grasu, Radu Dumitru, Gina Rusu, Mihai Toma, Ioana G. Lupescu
ORIGINAL PAPER, June 2017
Article DOI: 10.21614/jtmr-22-2-119
Purpose: The aim of this study is to describe the role of the percutaneous biliary drainage (PTBD) in the managament of patients with hepatic cholangiocarcinoma (CC) and also to assess outcomes and complications after PTBD procedures.

Methods and Materials: 225 consecutive patients with biliary obstruction managed by PTBD were included. All cases were performed by four consultant interventional radiologist between January 2014 and March 2016. Demografic data, patients history, the radiological data base, laboratory test from and following intervention, procedural records, clinical and imaging follow-up were reviewed. Pre procedure imaging with abdominal ultrasound and computed tomography was performed in all patients. Complications were grouped into immediate (occurring <24 hours) early ( 24 hours to 30 days) and late (>30 days). 30-day mortality was calculated.

Results: In total there were 111 male (49,3%) and 114 female (51,7 %). The mean age was 61,5 years and ranged from 88-27 years. The approach for PTBD was left sided in 21 cases (9,3%), and right sided in 204 cases (90,7%). There were 6 (<3%) technical failures giving a technical success rate of (97,3 %). These included 2 cases of bleeding and 4 cases were we were unable to cross the obstruction. The procedure related mortality was 5 (2,2 %), these included 4 cases of sepsis and 1 case of pneumonia secondary to pleural effusions post procedure.

Conclusion: PTBD represents a safe and valid method in providing palliative treatment for stage IV cholangiocarcinoma.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2337


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/